Analysis of fumarate hydratase mutations in a population‐based series of early onset uterine leiomyosarcoma patients

Germline mutations in fumarate hydratase (FH) gene at 1q43 predispose to hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome. In HLRCC, the most common clinical features are leiomyomas of the skin and uterus, and in a subset of the families, renal cell cancer (RCC) and uterine leiomyosarcoma (ULMS) occur frequently at young age. This study was conducted to evaluate the possible contribution of FH mutations in a population‐based series of early onset (≤45 years) ULMSs. Eighty‐one cases were identified through the national cancer registry, and samples from 67 cases (83%) were available for FH mutation screening and analysis of allelic imbalance (AI) at the FH locus. Seventeen percent of tumors showed AI. In the mutation analysis, a novel missense mutation K424R was found. The mutation was also found from the patient's normal tissue. To study whether this variant has functional consequences, FH enzyme activity assay was performed in a cell model. The activity of the mutated protein was significantly reduced as compared to wild type (p = 0.009). This study shows that FH germline mutations can occur in seemingly nonsyndromic cases of ULMS (1/67, 1.5%). It appears that on the population level hereditary FH defects do play a role in pathogenesis of sporadic early onset ULMSs, albeit rarely. © 2006 Wiley‐Liss, Inc.

[1]  J. McGrath,et al.  Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer , 2005, Clinical and experimental dermatology.

[2]  A. Berchuck,et al.  Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization , 1997, Molecular carcinogenesis.

[3]  P. Choyke,et al.  Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer , 2005, Journal of Medical Genetics.

[4]  L. Aaltonen,et al.  Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. , 2004, The American journal of pathology.

[5]  R. Houlston,et al.  Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas , 2002, British Journal of Cancer.

[6]  L. Aaltonen,et al.  Increased risk of cancer in patients with fumarate hydratase germline mutation , 2005, Journal of Medical Genetics.

[7]  L. Aaltonen,et al.  Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. , 2001, The American journal of pathology.

[8]  M. Hatch.  A simple spectrophotometric assay for fumarate hydratase in crude tissue extracts. , 1978, Analytical biochemistry.

[9]  S. de Vos,et al.  p53 alterations in uterine leiomyosarcomas versus leiomyomas. , 1994, Gynecologic oncology.

[10]  H. Moch,et al.  Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma , 2004, Journal of Clinical Pathology.

[11]  R. Barbieri,et al.  Uterine Leiomyomas: The Somatic Mutation Theory , 1992 .

[12]  W. Reed,et al.  Cutaneous leiomyomata with uterine leiomyomata. , 1973, Acta dermato-venereologica.

[13]  A. Paetau,et al.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.

[14]  A. Skubitz,et al.  Differential gene expression in leiomyosarcoma , 2003, Cancer.

[15]  B. Glaser,et al.  Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata. , 2005, Journal of the American Academy of Dermatology.

[16]  B. Glaser,et al.  Germline fumarate hydratase mutations in families with multiple cutaneous and uterine leiomyomata. , 2003, The Journal of investigative dermatology.

[17]  R. Houlston,et al.  No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas. , 2006, Cancer letters.

[18]  U. Surti,et al.  Genomic alterations in uterine leiomyosarcomas: Potential markers for clinical diagnosis and prognosis , 2001, Genes, chromosomes & cancer.

[19]  L. Aaltonen,et al.  Inherited susceptibility to uterine leiomyomas and renal cell cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Walker,et al.  Uterine Fibroids: The Elephant in the Room , 2005, Science.

[21]  D. Schaid,et al.  No fumarate hydratase (FH) mutations in hereditary prostate cancer , 2003, Journal of medical genetics.

[22]  P. Choyke,et al.  Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. , 2003, American journal of human genetics.

[23]  V. Launonen,et al.  Hereditary leiomyomatosis and renal cell cancer (HLRCC). , 2004, Current molecular medicine.

[24]  B. Delahunt,et al.  Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. , 2002, Cancer research.

[25]  A. Rowan,et al.  Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome. , 2005, Archives of dermatology.

[26]  N P Burrows,et al.  Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. , 2003, Human molecular genetics.

[27]  K. Hirschhorn,et al.  Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. , 2000, Cancer genetics and cytogenetics.

[28]  F. Amant,et al.  PTEN mutations in uterine sarcomas. , 2002, Gynecologic oncology.